CompoAtlas

RESVENUS NATTO K 105MG CAPSULE

RESVENUS NATTO K 105MG CAPSULE : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Glycine maxGlycine max[105 mg,350 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL21026095TC
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
Resvenus Niaga Sdn. Bhd.
Manufacturer
FINE JAPAN CO., LTD.
Importer
Resvenus Niaga Sdn. Bhd.
Registration period starting
2026-02-19
Published validity end
2031-02-19

Original register data

View published fields and their variants
Active ingredients
Glycine max[105 mg,350 mg]
Valid until
2031-02-19
Registration date
2026-02-19
Published description
NATURAL PRODUCT
Licence holder
Resvenus Niaga Sdn. Bhd.
Importer
Resvenus Niaga Sdn. Bhd.
Producer
FINE JAPAN CO., LTD.
Published name
RESVENUS NATTO K 105MG CAPSULE
Published reference
202008064081T
Registration number
MAL21026095TC
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL21026095TC

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Glycine max
    Read the warning, when it applies and the studies cited

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “RESVENUS NATTO K 105MG CAPSULE”, https://compoatlas.com/en/supplements/malaysia/MAL21026095TC-resvenus-natto-k-105mg-capsule, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line